![]() |
市場調查報告書
商品編碼
2088910
開放式磁振造影系統市場:按組件、磁場強度、成像模式、應用和最終用戶分類-2026-2032年全球市場預測Open MRI Systems Market by Component, Field Strength, Imaging Mode, Application, End Users - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2032 年,開放式 MRI 系統市場將成長至 31.2 億美元,複合年成長率為 8.45%。
| 主要市場統計數據 | |
|---|---|
| 基準年 2025 | 17.7億美元 |
| 預計年份:2026年 | 19.1億美元 |
| 預測年份 2032 | 31.2億美元 |
| 複合年成長率 (%) | 8.45% |
開放式磁振造影系統旨在使磁振造影(MRI)更易於被那些可能無法使用傳統封閉式掃描儀進行檢查的患者所接受,例如恐懼症患者、體型較大者、運動功能受限者、兒童患者,或在整形外科或介入檢查期間需要調整體位的患者。與磁振造影斷層掃描(CT)和X光影像不同,MRI不使用電離輻射,因此在神經影像學、肌肉骨骼影像、腫瘤檢查、心血管評估和後續觀察中繼續發揮重要作用。
開放式磁振造影系統的競爭格局正在發生變化,不再局限於患者舒適度和影像品質之間的傳統權衡。雖然低場和中場開放式磁振造影掃描儀在對成本和可及性要求較高的環境中仍然發揮著至關重要的作用,但磁體設計、梯度性能、線圈技術和重建軟體的進步正在提升更人性化的掃描儀配置的臨床價值。
人工智慧 (AI) 正在對整個開放式磁振造影 (MRI) 價值鏈產生累積效應。在影像擷取方面,AI 驅動的重建、降噪和運動校正可以縮短掃描時間並提高影像一致性。這對於焦慮的患者或難以保持靜止的患者尤其重要。同儕審查的放射學文獻表明,基於深度學習的重建在某些 MRI 應用中可以保持診斷效用,但臨床檢驗、法規核准和特定場所的方案管理仍然至關重要。
亞太地區擁有巨大的開放式磁振造影(MRI)系統發展潛力,這得益於日本、中國、韓國和澳洲龐大的病患群體、不斷擴展的私立醫院網路、日益完善的醫療保險覆蓋範圍以及顯著的老齡化人口。根據經合組織(OECD)的數據,日本的MRI密度一直位居世界前列,而中國和印度也持續擴大診斷基礎設施,以改善主要城市以外地區的醫療服務。在這些市場,對患者舒適度的需求、對肌肉骨骼影像的需求以及門診診斷能力的提升,都在推動開放式MRI的普及應用。
東協市場正透過對私人醫院集團、醫療旅遊走廊和公共衛生基礎設施的投資而不斷擴張,緊湊高效、服務便捷的開放式磁振造影系統在該地區日益受到關注,因為該地區將醫療服務的可及性和患者舒適度放在首位。海灣合作理事會(GCC)地區正受到國家醫療改革計劃、先進急診醫院建設以及對支持專科醫療、醫療旅遊和高品質患者體驗的先進影像診斷平台的需求的影響。
美國憑藉FDA監管下的創新、門診影像中心、大學附屬醫院以及對便於患者使用的MRI的強勁需求(例如,為恐懼症、肥胖症、兒童和行動不便的患者提供服務),在市場中佔據領先地位。加拿大的特點是省級政府採購、努力縮短公立醫療機構的等待時間,以及影像診斷服務在地理上的不均衡分佈。同時,墨西哥的市場受到私立醫院擴張和都市區對診斷服務需求的共同影響。巴西的公私混合醫療體係正在推動主要城市MRI的現代化,但保險報銷條件、進口成本和服務可近性仍具有顯著影響。
產業領導者應優先考慮經臨床驗證的影像品質、患者舒適度和工作流程效率,而不是僅將開放式磁振造影系統定位為恐懼症患者的替代方案。產品藍圖應重點關注更快速的掃描流程、人工智慧驅動的重配置、低維護磁鐵架構、遠距離診斷、網路安全、能源效率以及與現有放射科IT生態系統的兼容性。
本執行摘要基於醫療技術評估中常用的三角測量法,採用一級和二級調查方法。資訊來源包括監管資料庫、醫療設備指南、同行評審的放射學文獻、世界衛生組織、聯合國和經合組織等機構的公共衛生資料集、醫院採購模式、報銷標準、公共政策文件以及專家對診斷影像趨勢的解讀。
隨著醫療機構努力平衡患者就診便利性、影像品質、營運效率和資金管理,開放式磁振造影系統市場正進入更具戰略意義的階段。人口老化、慢性病負擔加重、門診診斷的擴展以及為不適合封閉式磁振造影環境的患者提供服務的需求,共同推動了市場需求的成長。
The Open MRI Systems Market is projected to grow by USD 3.12 billion at a CAGR of 8.45% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 1.77 billion |
| Estimated Year [2026] | USD 1.91 billion |
| Forecast Year [2032] | USD 3.12 billion |
| CAGR (%) | 8.45% |
Open MRI systems are designed to improve access to magnetic resonance imaging for patients who may not tolerate conventional closed-bore scanners, including individuals with claustrophobia, larger body habitus, mobility limitations, pediatric needs, or positioning requirements for orthopedic and interventional evaluation. Unlike computed tomography or X-ray imaging, MRI does not use ionizing radiation, supporting its continued role in neuroimaging, musculoskeletal imaging, oncology workups, cardiovascular assessment, and follow-up care.
The open MRI systems market is being shaped by three verified demand drivers: aging populations documented by the United Nations, rising chronic disease and musculoskeletal burden tracked by the World Health Organization, and uneven MRI equipment density reported across countries by OECD health statistics. Hospitals, diagnostic imaging centers, and specialty clinics are evaluating open magnetic resonance imaging platforms not only for patient comfort, but also for throughput, operating cost, image quality, serviceability, and integration with digital radiology workflows.
The competitive landscape for open MRI systems is moving beyond the historic trade-off between patient comfort and image quality. Low-field and mid-field open MRI scanners remain relevant for cost-sensitive and access-focused settings, while advances in magnet design, gradient performance, coil technology, and reconstruction software are improving the clinical value of more patient-friendly scanner configurations.
Procurement priorities are also shifting. Buyers increasingly evaluate total cost of ownership, installation footprint, energy consumption, remote service capabilities, cybersecurity, and compatibility with PACS, RIS, electronic health records, and cloud-based image exchange. The transition toward outpatient imaging, value-based care, and community diagnostic access is strengthening demand for MRI systems that can reduce exam abandonment, improve scheduling flexibility, and support safer scanning for a wider patient population.
Artificial intelligence is creating a cumulative effect across the open MRI value chain. In image acquisition, AI-assisted reconstruction, denoising, and motion correction can help shorten scan times and improve image consistency, which is especially important for anxious patients and individuals who struggle to remain still. Peer-reviewed radiology literature has shown that deep learning reconstruction can preserve diagnostic utility in selected MRI applications, although clinical validation, regulatory clearance, and site-specific protocol governance remain essential.
AI is also influencing workflow economics. Automated patient positioning, protocol recommendation, quality control, scan prioritization, report drafting support, and predictive maintenance can reduce operational friction in diagnostic imaging departments. For open MRI vendors, the strategic opportunity is not merely to add algorithms, but to deliver validated, auditable, cybersecurity-ready AI capabilities that integrate with radiologist workflows and comply with FDA, EU MDR, and local medical-device regulations.
Asia-Pacific is a high-potential region for open MRI systems due to large patient populations, expanding private hospital networks, rising health insurance penetration, and significant aging trends in Japan, China, South Korea, and Australia. OECD data consistently shows Japan among the countries with the highest MRI unit density, while China and India continue to expand diagnostic infrastructure to improve access beyond top-tier cities. In these markets, open MRI adoption is supported by patient comfort needs, musculoskeletal imaging demand, and the expansion of outpatient diagnostic capacity.
North America remains a leading region because of its mature radiology ecosystem, high adoption of outpatient imaging, advanced reimbursement frameworks, and strong replacement demand for MRI scanners. The United States and Canada also show sustained interest in patient-centered imaging models that reduce claustrophobia-related exam interruption and improve care access. Latin America is driven by private diagnostic chains, hospital modernization, and urban imaging demand in Brazil and Mexico, although public-sector budget constraints, import dependence, and service coverage gaps can slow broader open MRI adoption.
Europe benefits from universal health systems, established radiology standards, and demand for patient-centered imaging, but procurement is influenced by EU MDR compliance, energy efficiency, data protection, and regional tender cycles. The Middle East, particularly GCC countries, is investing in hospital capacity, specialty care, and medical tourism, strengthening demand for advanced and reliable MRI infrastructure. Africa remains underpenetrated in MRI access according to global imaging availability assessments, making affordability, uptime, workforce training, and local service networks decisive for open MRI deployment.
ASEAN markets are expanding through private hospital groups, medical tourism corridors, and public health infrastructure investment, making compact and service-efficient open MRI systems attractive where access and patient comfort are priorities. The GCC is shaped by national health transformation programs, high-acuity hospital development, and demand for advanced imaging platforms that support specialty care, medical tourism, and premium patient experience.
The European Union emphasizes regulatory compliance, cross-border device standards, sustainability, and data protection under frameworks such as EU MDR and GDPR, encouraging suppliers to demonstrate lifecycle safety, software governance, and interoperability. BRICS countries are important because they combine large patient bases with policy interest in local manufacturing, cost containment, and wider diagnostic access. These markets often require flexible financing, robust service models, and systems suited to diverse hospital environments.
G7 markets represent mature demand for replacement systems, AI-enabled workflow, lower operating burden, and evidence-based procurement tied to radiology productivity and patient outcomes. NATO countries are not a commercial bloc, but their health systems, military hospitals, and supply-chain resilience priorities reinforce demand for reliable, secure, and serviceable imaging infrastructure. Across these groups, successful open MRI strategies depend on aligning system performance with regulatory expectations, procurement discipline, and healthcare access goals.
The United States leads through FDA-regulated innovation, outpatient imaging centers, academic hospitals, and strong demand for patient-friendly MRI that supports claustrophobic, bariatric, pediatric, and mobility-limited patients. Canada is shaped by provincial procurement, public wait-time reduction initiatives, and geographically uneven imaging access, while Mexico combines private hospital expansion with urban diagnostic demand. Brazil's dual public-private system supports MRI modernization in major cities, though reimbursement conditions, import costs, and service availability remain influential.
In Europe, the United Kingdom is investing in diagnostic capacity through NHS recovery programs and community diagnostic models, strengthening interest in accessible MRI solutions. Germany benefits from a dense specialist care network and strong imaging utilization, France from national insurance coverage and structured hospital procurement, Italy and Spain from regional healthcare purchasing and modernization needs, and Russia from import substitution policies and supply-chain complexity that can influence technology availability and maintenance planning.
In Asia-Pacific, China emphasizes domestic medical-device development, hospital expansion, and broader access to advanced diagnostics; India is scaling imaging through private diagnostic chains, tertiary hospitals, and public insurance initiatives; and Japan's super-aging population sustains high MRI utilization documented in OECD equipment statistics. Australia relies on Medicare-supported imaging access and a mix of hospital and independent radiology providers, while South Korea combines advanced hospitals, high digital health adoption, and strong demand for efficient imaging workflows. Across these countries, open MRI system adoption is tied to patient comfort, scan completion, clinical confidence, uptime, and integration with radiology IT infrastructure.
Industry leaders should prioritize clinically validated image quality, patient comfort, and workflow efficiency rather than positioning open MRI systems only as alternatives for claustrophobic patients. Product roadmaps should emphasize faster protocols, AI-assisted reconstruction, low-maintenance magnet architecture, remote diagnostics, cybersecurity, energy efficiency, and compatibility with established radiology IT ecosystems.
Commercial strategies should be localized. Mature markets need replacement-cycle value, reimbursement evidence, cybersecurity assurance, and integration with outpatient imaging operations. Emerging markets require financing options, training programs, service uptime guarantees, and scalable installation models. Vendors that document total cost of ownership, exam completion rates, patient satisfaction, diagnostic performance, and protocol consistency will be better positioned in hospital tenders and private imaging network decisions.
This executive summary is based on triangulated secondary and primary research methods used in healthcare technology assessment. Inputs include regulatory databases, medical-device guidance, peer-reviewed radiology literature, public health datasets from organizations such as WHO, UN, and OECD, hospital procurement patterns, reimbursement references, public policy documents, and expert interpretation of diagnostic imaging trends.
The methodology emphasizes verifiable evidence over speculative claims. Market drivers were evaluated through installed-base indicators, demographic demand, technology adoption, clinical use cases, regulatory context, and regional healthcare infrastructure. AI-related conclusions were limited to validated workflow and image-processing applications with recognized requirements for clinical testing, governance, cybersecurity, and medical-device compliance.
The open MRI systems market is entering a more strategic phase as healthcare providers balance patient access, imaging quality, operational efficiency, and capital discipline. Demand is supported by aging populations, chronic disease burden, expanding outpatient diagnostics, and the need to serve patients who are poorly suited to closed-bore MRI environments.
Future progress will depend on vendors' ability to prove clinical performance, integrate AI responsibly, reduce lifecycle cost, and provide dependable service across both mature and emerging markets. Organizations that align open MRI innovation with patient-centered care, radiology workflow productivity, regulatory compliance, and evidence-based procurement will be best positioned to strengthen long-term adoption.